http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013203367-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7b35537a4a710d83dc40275f443db8a |
| publicationDate | 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013203367-B2 |
| titleOfInvention | Low frequency glatiramer acetate therapy |
| abstract | LOW FREQUENCY GLATIRAMER ACETATE THERAPY A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis comprising administering to the human patient three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a period of seven days with at least one day between every subcutaneous injection so as to thereby alleviate the symptom of the patient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE49251-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11167003-B2 |
| priorityDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.